Diagnostics manufacturer Abbott recently announced FDA clearance of the Afinion HbA1c Dx assay for use with the Afinion™ AS100 Analyzer. The assay is the first-ever rapid point-of-care test approved ...

A group of Axis-Shield shareholders has rejected Alere's £230 million ($375 million) takeover bid for the company, according to Scotland on Sunday. As the news service notes, the deal is now "dead in ...

BANGALORE/LONDON, Aug 24 (Reuters) - Axis-Shield , the British medical diagnostics firm fighting a takeover by U.S. rival Alere Inc , is open to considering an offer that values the company "more ...

ALERE, the US healthcare giant, yesterday extended the closing date for its unsolicited £230 million takeover offer for Scottish-Norwegian medical diagnostics kit maker Axis-Shield by about two weeks.

Alere, a Waltham-based company that provides health management solutions, doubled its stake in Axis-Shield PLC, a Scottish company that makes Afinion diagnostic tests. Alere, formerly Inverness ...

Since Alere's Rule 2.4 announcement on 6 July 2011, Axis-Shield has released a number of announcements, including its Interim Results for the six months ended 30 June 2011 (the "Interim Results") and ...

Axis-Shield Plc, the U.K. maker of the Afinion diagnostic tests, accepted a sweetened 235 million-pound ($364 million) bid from Alere Inc., ending a three-month takeover battle. Alere will pay 470 ...

Axis-Shield Plc, the maker of Afinion diagnostic tests, said a potential bidder for the company backed away after Alere Inc. doubled its stake. Alere, which has made a hostile, 460-pence-a-share bid ...